These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 3663266)
21. [The action of tiadenol on compensatory hypertrophy of the liver in the rat]. Rozé C; Vaille C; Souchard M; De la Tour J; Debray C Arch Int Pharmacodyn Ther; 1976 Jul; 222(1):166-76. PubMed ID: 984967 [TBL] [Abstract][Full Text] [Related]
22. Microsomal lauric acid hydroxylase activities after treatment of rats with three classical cytochrome P450 inducers and peroxisome proliferating compounds. Dirven HA; van den Broek PH; Peters JG; Noordhoek J; Jongeneelen FJ Biochem Pharmacol; 1992 Jun; 43(12):2621-9. PubMed ID: 1632818 [TBL] [Abstract][Full Text] [Related]
23. Role of 3,4-dichlorophenyl methyl sulfone, a metabolite of o-dichlorobenzene, in the changes in hepatic microsomal drug-metabolizing enzymes caused by o-dichlorobenzene administration in rats. Kato Y; Kimura R Toxicol Appl Pharmacol; 1997 Aug; 145(2):277-84. PubMed ID: 9266800 [TBL] [Abstract][Full Text] [Related]
24. The hypolipidemic peroxisome-proliferating drug, bis(carboxymethylthio)-1.10 decane, a dicarboxylic metabolite of tiadenol, is activated to an acylcoenzyme A thioester. Aarsland A; Berge RK; Bremer J; Aarsaether N Biochim Biophys Acta; 1990 Feb; 1033(2):176-83. PubMed ID: 2306462 [TBL] [Abstract][Full Text] [Related]
25. Hepatic microbody proliferation and catalase synthesis induced by methyl clofenapate, a hypolipidemic analog of CPIB. Reddy JK Am J Pathol; 1974 Apr; 75(1):103-18. PubMed ID: 4825610 [TBL] [Abstract][Full Text] [Related]
26. Regulation of CYP4A expression in rat by dehydroepiandrosterone and thyroid hormone. Webb SJ; Xiao GH; Geoghegan TE; Prough RA Mol Pharmacol; 1996 Feb; 49(2):276-87. PubMed ID: 8632760 [TBL] [Abstract][Full Text] [Related]
27. Drug control of steroid metabolism by the hepatic endoplasmic reticulum. Feuer G Drug Metab Rev; 1983; 14(6):1119-44. PubMed ID: 6373207 [TBL] [Abstract][Full Text] [Related]
28. Antihepatotoxic properties of uridine-diphosphoglucose in liver fluke infection. Experimental fascioliasis in the rat. Maffei Facino R; Carini M; Genchi C; Tofanetti O; Casciarri I; Bedoschi D Arzneimittelforschung; 1990 Apr; 40(4):490-8. PubMed ID: 2113387 [TBL] [Abstract][Full Text] [Related]
29. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice. Marsman D Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194 [TBL] [Abstract][Full Text] [Related]
30. [Effect of the cholesterol and protein diet on cytochrome P-450 dependent monooxygenase activity]. Plewka A; Kamiński M Med Pr; 1995; 46(1):17-23. PubMed ID: 9732843 [TBL] [Abstract][Full Text] [Related]
31. Influence of dietary carbohydrates (alpha-saccharides) on hepatic drug metabolism in male rats. Sonawane BR; Coates PM; Yaffe SJ; Koldovsky O Drug Nutr Interact; 1983; 2(1):7-16. PubMed ID: 6678749 [TBL] [Abstract][Full Text] [Related]
32. Dietary influences on the hepatic mixed-function oxidase system in the rat after portacaval anastomosis. Proia AD; Edwards KD; McNamara DJ; Anderson KE Gastroenterology; 1984 Apr; 86(4):618-26. PubMed ID: 6698363 [TBL] [Abstract][Full Text] [Related]
33. The effect of cyclosporine A on renal and hepatic microsomal mixed function oxidase systems in rats. Machková Z; Mostecká H; Seifert J; Masek K Methods Find Exp Clin Pharmacol; 1990 May; 12(4):239-44. PubMed ID: 2374470 [TBL] [Abstract][Full Text] [Related]
34. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289 [TBL] [Abstract][Full Text] [Related]
35. Effect of repeated administration of monomethyl-aminoantipyrine on the activities of gamma-glutamyltranspeptidase and microsomal drug metabolizing enzymes in rat liver. Hoshi K; Senda N; Igarashi T; Satoh T; Ueno K; Kitagawa H Res Commun Chem Pathol Pharmacol; 1985 Jun; 48(3):431-43. PubMed ID: 2862671 [TBL] [Abstract][Full Text] [Related]
36. Dietary cholesterol-induced changes of xenobiotic metabolism in liver. II. Effects of phenobarbitone and carbon tetrachloride on activities of drug-metabolizing enzymes. Hietanen E; Ahotupa M; Heikelä A; Laitinen M Drug Nutr Interact; 1982; 1(4):313-27. PubMed ID: 6821390 [TBL] [Abstract][Full Text] [Related]
37. Concurrent subacute exposure to arsenic through drinking water and malathion via diet in male rats: effects on hepatic drug-metabolizing enzymes. Naraharisetti SB; Aggarwal M; Sarkar SN; Malik JK Arch Toxicol; 2008 Aug; 82(8):543-51. PubMed ID: 18528686 [TBL] [Abstract][Full Text] [Related]
38. Enzymatic changes in rat liver associated with low and high doses of a peroxisome proliferator. Berge RK; Hosøy LH; Aarsland A; Bakke OM; Farstad M Toxicol Appl Pharmacol; 1984 Mar; 73(1):35-41. PubMed ID: 6143426 [TBL] [Abstract][Full Text] [Related]
39. Effect of hypolipidemic compounds on lauric acid hydroxylation and phase II enzymes. Thomas H; Schladt L; Knehr M; Post K; Oesch F; Boiteux-Antoine AF; Fournel-Gigleux S; Magdalou J; Siest G Biochem Pharmacol; 1989 Jun; 38(12):1963-9. PubMed ID: 2500933 [TBL] [Abstract][Full Text] [Related]
40. [Induction by kopsinine of hepatic mixed-function oxidase in mice]. Huang WY; Liu GT Zhongguo Yao Li Xue Bao; 1990 May; 11(3):264-8. PubMed ID: 2088003 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]